UT Southwestern Medical Center
Hans Hammers, M.D., Ph.D., is an Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center. He is the first Eugene P. Frenkel, M.D. Scholar in Clinical Medicine.
Dr. Hammers received his M.D. and Ph.D. from the Medical University of Luebeck in Germany. He completed his residency in internal medicine at Johns Hopkins Bayview Medical Center and performed his fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Also at Johns Hopkins, Dr. Hammers led the kidney cancer research efforts and played a major role in the development of immunotherapy with immune checkpoint inhibitors in kidney cancer. His work in immunotherapy has been nationally recognized, and he has been the principal investigator on several industry- and investigator-sponsored trials.
Dr. Hammers joined the UT Southwestern faculty in 2016. He is co-leader of clinical research and immunotherapy for the kidney cancer research program and will be continuing his research efforts to develop novel immunotherapies for kidney cancer.
Aveo (Individual(s) Involved: Self): Advisory Board, Grant/Research Support; BMS (Individual(s) Involved: Self): Advisory Board, Grant/Research Support; Exelixis (Individual(s) Involved: Self): Advisory Board, Grant/Research Support; Merck (Individual(s) Involved: Self): Advisory Board, Grant/Research Support; Novartis Pharma (Individual(s) Involved: Self): Advisory Board; Pfizer (Individual(s) Involved: Self): Advisory Board; Surface Oncology (Individual(s) Involved: Self): Grant/Research Support
Wednesday, March 9, 2022
9:00 AM – 11:15 AM
Wednesday, March 9, 2022
10:05 AM – 10:13 AM
Wednesday, March 9, 2022
10:21 AM – 10:25 AM
Wednesday, March 9, 2022
10:25 AM – 11:15 AM
Thursday, September 29, 2022
9:40 AM – 11:50 AM
Thursday, September 29, 2022
10:12 AM – 10:19 AM
Thursday, September 29, 2022
10:19 AM – 10:25 AM
Thursday, September 29, 2022
11:25 AM – 11:50 AM